NRx Pharmaceuticals, Inc.

NRx Pharmaceuticals, Inc.

NRXPW
NRx Pharmaceuticals, Inc.US flagNASDAQ Global Market
0.01
USD
- -
- -
361,784.00Market Cap

Income Statement (USD)

APIChatGPT
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
1
+ Sales & Services Revenue
- -
- -
- -
- -
- -
1
- Cost of Revenue
- -
- -
- -
- -
- -
1
+ Cost of Goods & Services
- -
- -
- -
- -
- -
1
Gross Profit
- -
- -
- -
- -
- -
1
+ Other Operating Income
- -
- -
- -
- -
- -
- -
- Operating Expenses
12
94
44
28
19
17
+ Selling, General & Admin
11
75
27
14
14
13
+ Research & Development
11
20
17
13
6
4
+ Other Operating Expense
-10
-1
- -
- -
-1
- -
Operating Income (Loss)
-12
-94
-44
-28
-19
-16
- Non-Operating (Income) Loss
40
-1
-5
3
7
12
+ Interest Expense, Net
- -
- -
- -
- -
- -
1
+ Interest Expense
- -
- -
- -
- -
- -
1
- Interest Income
- -
- -
- -
- -
- -
- -
+ Other Non-Op (Income) Loss
40
-1
-4
3
6
12
Pretax Income
-52
-93
-40
-30
-25
-29
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
-52
-93
-40
-30
-25
-29
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
-52
-93
-40
-30
-25
-29
- Minority Interest
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-52
-93
-40
-30
-25
-29
- Preferred Dividends
- -
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-52
-93
-40
-30
-25
-29
EBIT
-12
-94
-44
-28
-19
-16
EBITDA
-12
-94
-44
-28
-18
-16
EBITDA Margin (%)
- -
- -
- -
- -
- -
-1,312.73
EBITA
-12
-94
-44
-28
-19
-16
Gross Margin (%)
- -
- -
- -
- -
- -
58.78
Operating Margin (%)
- -
- -
- -
- -
- -
-1,324.41
Profit Margin (%)
- -
- -
- -
- -
- -
-2,336.49
Sales per Employee
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
Basic EPS, GAAP
- -
- -
- -
- -
- -
- -
Basic EPS from Cont Ops
- -
- -
- -
- -
- -
- -
Diluted Weighted Avg Shares
- -
- -
- -
- -
- -
- -
Diluted EPS, GAAP
- -
- -
- -
- -
- -
- -
Diluted EPS from Cont Ops
- -
- -
- -
- -
- -
- -

Balance Sheet (USD)

APIChatGPT
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Total Current Assets
3
33
26
7
3
9
+ Cash, Cash Equivalents & STI
2
28
20
5
1
8
+ Cash & Cash Equivalents
2
28
20
5
1
8
+ ST Investments
- -
- -
- -
- -
- -
- -
+ Accounts & Notes Receiv
1
- -
- -
- -
- -
- -
+ Accounts Receivable, Net
1
- -
- -
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
- -
- -
- -
+ Inventories
- -
- -
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
- -
+ Other ST Assets
- -
5
6
2
2
1
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
- -
- -
- -
- -
- -
4
+ Property, Plant & Equip, Net
- -
- -
- -
- -
- -
1
+ Property, Plant & Equip
- -
- -
- -
- -
- -
1
- Accumulated Depreciation
- -
- -
- -
- -
- -
- -
+ LT Investments & Receivables
- -
- -
- -
- -
- -
- -
+ LT Investments
- -
- -
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
- -
- -
+ Other LT Assets
- -
- -
- -
- -
- -
3
+ Total Intangible Assets
- -
- -
- -
- -
- -
3
+ Goodwill
- -
- -
- -
- -
- -
2
+ Other Intangible Assets
- -
- -
- -
- -
- -
1
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
- -
- -
- -
- -
- -
- -
Total Assets
3
33
26
7
4
13
+ Payables & Accruals
46
7
8
9
9
10
+ Accounts Payable
3
4
2
5
4
4
+ Accrued Taxes
- -
- -
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
43
3
6
4
5
6
+ ST Debt
- -
1
8
9
2
- -
+ ST Borrowings
- -
1
8
9
2
- -
+ ST Finance Leases
- -
- -
- -
- -
- -
- -
+ Other ST Liabilities
- -
5
- -
1
11
18
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
+ Misc ST Liabilities
- -
5
- -
1
11
18
Total Current Liabilities
46
12
16
19
22
29
+ LT Debt
1
- -
3
- -
5
- -
+ LT Borrowings
1
- -
3
- -
5
- -
+ LT Finance Leases
- -
- -
- -
- -
- -
- -
+ Other LT Liabilities
- -
- -
- -
- -
- -
- -
+ Accrued Liabilities
- -
- -
- -
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
- -
- -
- -
- -
- -
- -
Total Noncurrent Liabilities
1
- -
3
- -
5
- -
Total Liabilities
47
12
18
19
27
29
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
- -
- -
+ Share Capital & APIC
46
204
230
241
255
291
+ Common Stock
- -
- -
- -
- -
- -
- -
+ Additional Paid in Capital
46
204
230
241
255
291
- Treasury Stock
- -
- -
- -
- -
- -
- -
+ Retained Earnings
-90
-183
-223
-253
-278
-307
+ Other Equity
- -
- -
- -
- -
- -
- -
Equity Before Minority Interest
-44
21
7
-12
-23
-16
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
- -
Total Equity
-44
21
7
-12
-23
-16
Total Liabilities & Equity
3
33
26
7
4
13
Shares Outstanding
- -
6
7
8
15
32
Number of Employees
- -
- -
- -
- -
- -
- -
Capital Leases - Total
- -
- -
- -
- -
- -
1
Net Debt
-1
-27
-10
5
5
-8
Net Debt to Equity
2.43
-130.19
-128.61
-38.92
-22.11
48.92
Tangible Common Equity Ratio
-1,488.3
63.57
28.7
-160.44
-636.07
-182.21
Current Ratio
0.06
2.74
1.66
0.36
0.15
0.31
Cash Conversion Cycle
- -
- -
- -
- -
- -
-3,011.66

Cash Flow Statement (USD)

APIChatGPT
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
+ Net Income
-52
-93
-40
-30
-25
-29
+ Depreciation & Amortization
- -
- -
- -
- -
- -
- -
+ Non-Cash Items
46
60
-1
3
9
13
+ Stock-Based Compensation
1
8
4
- -
- -
- -
+ Deferred Income Taxes
- -
- -
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
- -
- -
+ Other Non-Cash Adj
45
52
-4
3
9
13
+ Chg in Non-Cash Work Cap
3
-5
1
5
5
1
+ (Inc) Dec in Accts Receiv
-1
1
- -
- -
- -
- -
+ (Inc) Dec in Inventories
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
- -
-5
-1
3
1
1
+ Inc (Dec) in Accts Payable
4
-1
1
2
5
1
+ Inc (Dec) in Other
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
Cash from Operating Activities
-2
-38
-40
-22
-11
-14
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
- -
- -
- -
- -
- -
+ Acq of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
3
37
23
8
6
16
+ Increase in Capital Stock
3
37
23
8
6
16
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
- -
+ Net Change in LT Investment
- -
- -
- -
- -
- -
- -
+ Dec in LT Investment
- -
- -
- -
- -
- -
- -
+ Inc in LT Investment
- -
- -
- -
- -
- -
- -
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
-2
+ Cash from Divestitures
- -
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
-2
+ Cash for JVs
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
Cash from Investing Activities
- -
- -
- -
- -
- -
-3
+ Dividends Paid
- -
- -
- -
- -
- -
- -
+ Net Cash From Debt
1
-3
9
-3
-1
5
+ Cash From Debt
1
- -
10
1
7
5
+ Repayments of Debt
- -
-3
-1
-4
-9
-1
+ Other Financing Activities
- -
29
1
1
3
3
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
3
63
32
6
7
23
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
- -
Net Changes in Cash
1
26
-8
-15
-3
6
EBITDA
-12
-94
-44
-28
-18
-16
EBITDA Margin (%)
- -
- -
- -
- -
- -
-1,312.73
Free Cash Flow
-2
-38
-40
-22
-11
-14
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
2
Free Cash Flow to Firm
- -
- -
- -
- -
- -
- -
Free Cash Flow to Equity
- -
-40
-31
-25
-12
-9
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
Price/Free Cash Flow
- -
- -
- -
- -
- -
- -
Cash Flow to Net Income
0.04
0.41
1
0.72
0.42
0.49
Capital Expenditures
- -
- -
- -
- -
- -
- -